Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, Wood B, Maloney DG, Jensen MC, Rader C, Riddell SR. Hudecek M, et al. Among authors: nishida t. Blood. 2010 Nov 25;116(22):4532-41. doi: 10.1182/blood-2010-05-283309. Epub 2010 Aug 11. Blood. 2010. PMID: 20702778 Free PMC article.
Adoptive transfer of allogeneic antigen-specific T cells.
Riddell SR, Bleakley M, Nishida T, Berger C, Warren EH. Riddell SR, et al. Among authors: nishida t. Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):9-12. doi: 10.1016/j.bbmt.2005.10.025. Biol Blood Marrow Transplant. 2006. PMID: 16399578 Free article. Review.
Adoptive T-cell therapy for B-cell malignancies.
Hudecek M, Anderson LD Jr, Nishida T, Riddell SR. Hudecek M, et al. Among authors: nishida t. Expert Rev Hematol. 2009 Oct;2(5):517-32. doi: 10.1586/ehm.09.47. Expert Rev Hematol. 2009. PMID: 21083018 Free PMC article. Review.
The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.
Brickner AG, Evans AM, Mito JK, Xuereb SM, Feng X, Nishida T, Fairfull L, Ferrell RE, Foon KA, Hunt DF, Shabanowitz J, Engelhard VH, Riddell SR, Warren EH. Brickner AG, et al. Among authors: nishida t. Blood. 2006 May 1;107(9):3779-86. doi: 10.1182/blood-2005-08-3501. Epub 2006 Jan 3. Blood. 2006. PMID: 16391015 Free PMC article.
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.
Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H. Tawara I, et al. Among authors: nishida t. Blood. 2017 Nov 2;130(18):1985-1994. doi: 10.1182/blood-2017-06-791202. Epub 2017 Aug 31. Blood. 2017. PMID: 28860210 Free article. Clinical Trial.
Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.
Watanabe K, Terakura S, Martens AC, van Meerten T, Uchiyama S, Imai M, Sakemura R, Goto T, Hanajiri R, Imahashi N, Shimada K, Tomita A, Kiyoi H, Nishida T, Naoe T, Murata M. Watanabe K, et al. Among authors: nishida t. J Immunol. 2015 Feb 1;194(3):911-20. doi: 10.4049/jimmunol.1402346. Epub 2014 Dec 17. J Immunol. 2015. PMID: 25520398
2,777 results